Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1985 2
1986 2
1987 2
1988 7
1989 4
1990 3
1991 6
1992 6
1993 14
1994 3
1995 7
1996 4
1997 8
1998 2
1999 5
2000 13
2001 7
2002 6
2003 10
2004 6
2005 7
2006 7
2007 4
2008 10
2009 8
2010 6
2011 7
2012 5
2013 17
2014 21
2015 17
2016 22
2017 19
2018 50
2019 103
2020 98
2021 91
2022 74
2023 63
2024 44
2025 56
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

783 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
BACKGROUND: Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effec …
BACKGROUND: Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly pu …
Vascepa patents under legal scrutiny.
Curfman G, Cole J. Curfman G, et al. Nat Biotechnol. 2022 Jun;40(6):829-831. doi: 10.1038/s41587-022-01345-8. Nat Biotechnol. 2022. PMID: 35705703 No abstract available.
Pharmacoeconomic Review Report: Icosapent Ethyl (Vascepa): (HLS Therapeutics Inc.): Indication: Prevention of cardiovascular events in statin-treated patients.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Aug. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Aug. PMID: 33355725 Free Books & Documents. Review.
Icosapent ethyl is available in 1 g capsules with a recommended daily dose of 4 g, taken as two 1 g capsules twice daily. ...Relative treatment effects and costs for icosapent ethyl plus statins were applied for the first five years of the model time h …
Icosapent ethyl is available in 1 g capsules with a recommended daily dose of 4 g, taken as two 1 g capsules twice daily. ...R …
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.
Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, Francis GA, Genest J, Grégoire J, Grover SA, Gupta M, Hegele RA, Lau D, Leiter LA, Leung AA, Lonn E, Mancini GBJ, Manjoo P, McPherson R, Ngui D, Piché ME, Poirier P, Sievenpiper J, Stone J, Ward R, Wray W. Pearson GJ, et al. Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26. Can J Cardiol. 2021. PMID: 33781847
Vascepa protects against high-fat diet-induced glucose intolerance, insulin resistance, and impaired beta-cell function.
Al Rijjal D, Liu Y, Lai M, Song Y, Danaei Z, Wu A, Mohan H, Wei L, Schopfer FJ, Dai FF, Wheeler MB. Al Rijjal D, et al. iScience. 2021 Jul 28;24(8):102909. doi: 10.1016/j.isci.2021.102909. eCollection 2021 Aug 20. iScience. 2021. PMID: 34458694 Free PMC article.
In the present study, mice were treated with Vascepa or Lovaza for one week prior to six weeks of high-fat diet feeding. Vascepa but not Lovaza led to reduced insulin resistance, reduced fasting insulin and glucose, and improved glucose intolerance. ...Vascepa …
In the present study, mice were treated with Vascepa or Lovaza for one week prior to six weeks of high-fat diet feeding. Vascepa …
Clinical Review Report: Icosapent Ethyl (Vascepa): (HLS Therapeutics Inc.): Indication: Prevention of cardiovascular events in statin-treated patients.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Aug. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Aug. PMID: 33355724 Free Books & Documents. Review.
The objective of the current review is to perform a systematic review of the beneficial and harmful effects of icosapent ethyl for the indication....
The objective of the current review is to perform a systematic review of the beneficial and harmful effects of icosapent ethyl …
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Budoff MJ, Bhatt DL, Kinninger A, Lakshmanan S, Muhlestein JB, Le VT, May HT, Shaikh K, Shekar C, Roy SK, Tayek J, Nelson JR. Budoff MJ, et al. Eur Heart J. 2020 Oct 21;41(40):3925-3932. doi: 10.1093/eurheartj/ehaa652. Eur Heart J. 2020. PMID: 32860032 Free PMC article. Clinical Trial.
AIMS: Despite the effects of statins in reducing cardiovascular events and slowing progression of coronary atherosclerosis, significant cardiovascular (CV) risk remains. Icosapent ethyl (IPE), a highly purified eicosapentaenoic acid ethyl est …
AIMS: Despite the effects of statins in reducing cardiovascular events and slowing progression of coronary atherosclerosis, significant card …
Lipid-lowering drugs.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. Med Lett Drugs Ther. 2019. PMID: 30845106 No abstract available.
783 results